Cadence Design Systems (CDNS) 51st Nasdaq London Investor Conference summary

Business performance and financial outlook

• Achieved over 13% revenue growth and more than 42% operating margin for the year, maintaining a Rule of 40 score above 55 for several years.

• Revenue is highly predictable, with 82%-83% ratable recurring revenue and 16%-17% upfront, though this year was more back-end loaded due to new product launches and IP contracts.

• Operating margin improvement is expected as the company continues to scale, with a focus on efficiency and value compounding.

• Top 50 customers contribute 60%-70% of revenue, with collaborative relationships and value-based pricing models.

• Hardware segment has seen record years, with strong positioning and optimism for continued growth into 2025 and beyond.

Product innovation and AI strategy

• Focused on EDA (chip design), SDA (system design), and AI, leveraging computational software expertise across silicon, system, and data.

• AI is integrated in three phases: infrastructure (AI chip design), applying AI to internal products, and creating new markets/products.

• AI-driven tools reduce chip design time from months to weeks and deliver 10%-15% better power efficiency, equivalent to a full technology node migration.

• AI enables workflow automation, knowledge transfer, and talent uplift across design teams, optimizing complex, multivariate processes.

• Customers are expected to increase R&D spend on software and compute, with EDA's share potentially rising from 11% to 15% by 2030.

Market opportunities and industry trends

• Data center silicon is a major growth driver, with the market expected to expand by $200-$400 billion, fueled by AI infrastructure build-out.

• Automotive semiconductor content per vehicle is projected to rise from $400 to $2,000-$4,000, creating a $200-$400 billion opportunity.

• Physical AI (autonomous vehicles, drones, robots) and sciences AI (biosimulation, drug discovery) are identified as future high-growth verticals.

• The company is investing in biosimulation and life sciences, aiming to be relevant across infrastructure, physical, and sciences AI phases.

• Automotive and China are key focus areas, with recent acquisitions and customer activity supporting long-term growth.